mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.01 |
mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |